Kevin Baynes - Concepedia

Author

Kevin Baynes

Also Known As

K Baynes, K C Baynes, K. C. Baynes, K. C. R. Baynes, K. C.R. Baynes, KEVIN C. R. BAYNES, Kevin Baynes, Kevin C Baynes, Kevin C. Baynes, Kevin C. R. Baynes

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Imperial College London University College London Hammersmith Hospital Chelsea and Westminster Hospital Royal London Hospital

About

Kevin Baynes is an author at Imperial College London specializing in diabetes, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Diabetes	6	6	1.3K
3	Health Sciences	5	5	871
4	Cell Biology	1	1	56
5	Clinical Nutrition	1	1	311

Kevin Baynes

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial Francesco D’Aiuto, Nikolaos Gkranias, Devina Bhowruth, The Lancet Diabetes & Endocrinology Diabetes ManagementPeriodontitis TreatmentRandomised TrialDiabetesType 2	2018	467
Vitamin D, glucose tolerance and insulinaemia in elderly men Kevin Baynes, Barbara J. Boucher, Edith J. M. Feskens, Diabetologia ObesityMetabolic SyndromeBody CompositionMedicineInsulin Management	1997	311
Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia Tricia Tan, Benjamin C. T. Field, K. McCullough, Diabetes NutritionProglucagon ProcessingGlucose ToleranceInsulin SignalingGastrointestinal Peptide Hormone	2012	258
Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism Fariba Shojaee‐Moradie, Kevin Baynes, Claire Pentecost, Diabetologia Metabolic SyndromeInsulin SensitivityPhysical ActivityKinesiologyExercise	2006	210
PYY3–36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans Benjamin C. T. Field, Alison Wren, Véronique Peters, Diabetes	2010	113
ORIGINAL ARTICLE: Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia Tricia Tan, Inês Zimbarra Cabrita, Davina J. Hensman Moss, Clinical Endocrinology	2010	57
Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. Karim Dib, Jonathan P. Whitehead, P Humphreys, Journal of Clinical Investigation Insulin ResistanceMetabolic SyndromeInsulin SignalingSignal TransductionSevere Insulin Resistance	1998	56
Natural variants of human p85α phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity Kevin Baynes, Caroline A. Beeton, George Panayotou, Diabetologia Insulin ResistanceMetabolic SyndromeNovel VariantInsulin SignalingMolecular Physiology	2000	36
Combination of Peptide YY<sub>3–36</sub>with GLP-1<sub>7–36 amide</sub>Causes an Increase in First-Phase Insulin Secretion after IV Glucose Tricia Tan, Victoria Salem, R. Troke, The Journal of Clinical Endocrinology & Metabolism	2014	31
Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency Christiane Albrecht, Kevin Baynes, Alessandro Sardini, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Mendelian DisorderAltered TraffickingGenetic DisorderGeneticsInherited Metabolic Disease	2004	31

Page 1